Risk Assessment of BRONJ in Oncologic Patients Treated with Bisphosphonates: Follow-Up to 18 Months

Figure 2

FMBS detected before the start of therapy (T0) and 3 months (T1), 6 months (T2), and 18 months (T3) after. The patient S.V. died before the follow-up at 18 months.